Cargando…
AB085. Immune therapy: new option for prostate cancer
OBJECTIVE: Immunotherapy has emerged as another treatment modality in cancer. Appropriate combination of tumor mass reduction and neutralization of tumor-induced immunosuppression might set the right conditions for the induction of anti-tumor immune response. Besides the direct cytotoxic effect on t...
Autores principales: | Wang, Wei, Chen, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708704/ http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s085 |
Ejemplares similares
-
AB010. Metabolic disturbance for prostate cancer therapy
por: Li, Benyi
Publicado: (2018) -
AB025. The effects and mechanisms of magnetic nanomaterials in prostate cancer diagnosis and therapy
por: Zhang, Li
Publicado: (2018) -
AB012. Brachytherapy for localized prostate cancer
por: Xu, Yong, et al.
Publicado: (2016) -
AB084. Docetaxel therapy for hormone-sensitive prostate cancer—single center result
por: Shao, Qiang, et al.
Publicado: (2015) -
AB271. Sexual dysfunction in chronic prostatitis
por: Cho, In-Rae
Publicado: (2016)